Trial intelligence / Profile preview

Bisoprolol resting heart rate and prognosis study in coronary artery disease

ChiCTR-OPN-15007091Phase 4Completed

Sponsor
Chinese PLA General Hospital
Start
Oct 2011
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of bisoprolol in coronary arteriosclerosis, sponsored by Chinese PLA General Hospital. Primary endpoints: Composite cardiac clinical outcomes and Resting heart rate. Started Oct 2011; status: completed.

02

Drugs

bisoprolol
03

Conditions

coronary arteriosclerosis

Beyond the preview

Go deeper on ChiCTR-OPN-15007091.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-OPN-15007091.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call